Retrophin Inc (NASDAQ:RTRX)

30.05
Delayed Data
As of Jul 17
 +1.26 / +4.38%
Today’s Change
18.91
Today|||52-Week Range
30.18
+42.62%
Year-to-Date
No recent news for Retrophin Inc.

Today’s Trading

Previous close28.79
Today’s open28.62
Day’s range28.62 - 30.18
Volume285,278
Average volume (3 months)309,818
Market cap$1.1B
Data as of 4:00pm ET, 07/17/2018

Growth & Valuation

Earnings growth (last year)-19.38%
Earnings growth (this year)-215.38%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+15.98%
P/E ratioNM
Price/Sales5.27
Price/Book3.59

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...+0.20+1.16%
EDITEditas Medicine Inc+1.26+3.58%
EPZMEpizyme Inc-0.15-1.09%
----
Data as of 4:00pm ET, 07/17/2018

Financials

Next reporting dateJuly 27, 2018
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$154.9M
Annual profit (last year)-$59.7M
Net profit margin-38.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen J. Aselage
Chief Operating Officer
Neil F. McFarlane
Corporate headquarters
San Diego, California

Forecasts